Elsevier

International Immunopharmacology

Volume 62, September 2018, Pages 237-243
International Immunopharmacology

Immunomodulatory effect of 1, 25 dihydroxy vitamin D3 on the expression of RNA sensing pattern recognition receptor genes and cytokine response in dengue virus infected U937-DC-SIGN cells and THP-1 macrophages

https://doi.org/10.1016/j.intimp.2018.07.019Get rights and content

Highlights

  • Vitamin D (1,25(OH)2D3) affect immune receptors and cytokines in dengue virus infected monocytes.

  • 1,25(OH)2D3 increased the expression of DDX58, OAS1, OAS2 and OAS3 at 0.1 μM dose

  • 1,25(OH)2D3 suppressed the levels of IL-4 and IL-17A.

  • Lower dose of 1,25(OH)2D3 suppressed IL-12p70 and IL-10 while a higher dose enhanced the levels.

  • 1,25(OH)2D3 has a role in reducing inflammation in dengue infections.

Abstract

Dengue virus (DENV) infections are straining public health systems worldwide. Vitamin D, a secosteroid hormone, is currently being investigated for its immunomodulatory effects in DENV infections. The objectives of the present study was to study the effect of 1, 25 dihydroxy vitamin D3 (1,25(OH)2D3) on the expression of genes coding for RNA sensing pattern recognition receptors, downstream signaling components including oligoadenylate synthetases (OAS) and interferon stimulated gene 15 (ISG15) and T helper (Th)1, Th2 and Th17 cytokine response in DENV infected U937-DC-SIGN cells and THP-1 macrophages. U937-DC-SIGN RNA was investigated for the expression of TLR3, DDX58, IFIH1, OAS1, OAS2, OAS3, CAMP and ISG15 genes using gene expression assays. Interleukin (IL)-12p70, IL-10, IL-4 and IL-17A levels were assessed in the THP-1 macrophage culture supernatants. The results revealed that 1,25(OH)2D3 increased the expression of DDX58, OAS1, OAS2 and OAS3 at 0.1 μM while higher concentration had diminishing effect. 1,25(OH)2D3 enhanced the expression of ISG15 and CAMP genes. 1,25(OH)2D3 suppressed the levels of IL-4 and IL-17A. Lower concentration of 1,25(OH)2D3 suppressed IL-12p70 and IL-10 levels while a higher concentration enhanced the levels. The results suggest that 1,25(OH)2D3 may have concentration dependent immunomodulatory effects. Higher dose of 1,25(OH)2D3 might have an immunoregulatory role in ameliorating inflammation during dengue infections. Further studies are needed to evaluate the efficacy of different doses of 1,25(OH)2D3 in preventing severe dengue.

Introduction

Dengue and severe dengue caused by the antigenically distinct four serotypes of dengue virus (DENV) is a serious concern worldwide. Currently, there are no antiviral drugs available against the virus. A vaccine named dengvaxia has been approved for use in certain countries but the vaccine is efficacious only in children greater than five years old with previous exposure to dengue [1]. Progression to severe dengue which is occasionally fatal, if not treated properly, depends on multiple factors involving virus and host. Immune status depending on previous exposure to the virus, and cytokine network signature elicited in the context of host immunogenetic background are important in deciding the progression to severe dengue [2]. Hence, drugs that are developed against DENV should not only have antiviral activity but also be able to modulate the host inflammatory response involving cytokines to prevent subsequent vascular leakage, a characteristic of severe dengue.

Vitamin D, a secosteroid hormone, known to have both antiviral and immunomodulatory effects, is being investigated for its antiviral activity against many viruses. Solar radiations trigger the synthesis of 25 hydroxy vitamin D (25OHD) which is converted into 1, 25 dihydroxy vitamin D3 (1,25(OH)2D3), the active form of vitamin D. 1,25(OH)2D3 binds to a nuclear receptor called vitamin D receptor (VDR) which subsequently forms a complex with retinoid X receptor (RXR). 1,25(OH)2D3-VDR-RXR complex translocates to the nucleus to bind to vitamin D response elements in the proximal region of vitamin D responsive genes to enhance innate immunity and suppress inflammatory cytokine in different diseases [3]. Vitamin D is known to induce the production of cathelicidin antimicrobial peptide (CAMP) and LL-37, the active form of CAMP, is known to possess direct antiviral activity against dengue [3, 4].

Many studies have shown the association of deficiency of 25OHD with susceptibility to infectious diseases [5]. In contrast, our earlier study has shown elevated levels of 25OHD in dengue hemorrhagic fever patients (DHF) [6]. Another study has reported that low levels of 25OHD predict decreased odds of progression to severe forms of dengue [7]. Our study has also reported the association between VDR gene variants and susceptibility to DHF [8]. Recent studies have shown that 1,25(OH)2D3 reduces the susceptibility of human macrophages and monocytes to DENV [[9], [10], [11]].

RNA sensing pattern recognition receptors (PRRs) such as retinoic acid inducible gene-1 (RIG-1), myeloid differentiation gene-5 (MDA-5) and toll like receptor-3 (TLR-3) have been implicated in sensing DENV and induction of type I interferon response [12, 13]. Type I interferon response triggers the activation of many components involved in restricting viral replication including 2′–5′ oligoadenylate synthetases (OAS) and interferon stimulated gene (ISG) products. Different isoforms of OAS have been reported to have anti DENV activity [14]. ISG15, an ubiquitin like molecule, has been reported to mediate inhibition of DENV-2 replication [15]. Cellular immune response against DENV elicits an array of cytokine response including T helper cell 1 (Th1), Th2 and Th17 cytokines that are implicated in the pathogenesis of severe dengue [2].

In the present study, the effect of 1,25(OH)2D3 on the expression of RNA sensing PRRs and cytokine response involving Th1, Th2 and Th17 cytokines during DENV infection were investigated in a monocytic cell line expressing the dendritic cell specific intercellular adhesion molecule (ICAM) 3 grabbing non integrin (DC-SIGN), a receptor for DENV entry, and another monocytic cell line differentiated into macrophages using Phorbol-12-Myristate-13-Acetate (PMA) treatment.

Section snippets

Cell lines, viruses and reagents

Vero E6 (ATCC CRL-1586), Aedes albopictus clone C6/36 (ATCC CRL-1660), and U937-DC-SIGN (ATCC CRL-3253) cell lines were obtained from American Type Culture Collection (ATCC). THP-1 cell line was obtained from National Centre for Cell Science (NCCS), India. Dengue virus type 2 (DENV-2) (Indian strain 803347) from the repository of ICMR-National Institute of Virology, Pune, India was used in all experiments. Vero E6 and C6/36 cell lines were maintained in minimal essential medium (MEM) (Gibco,

Effect of 1,25(OH)2D3 on dengue virus replication in monocytic cell lines

Pretreatment of U937-DC-SIGN cells with 1,25(OH)2D3 before DENV-2 infection or addition of 1,25(OH)2D3 to PMA differentiated cultures of THP-1 macrophages after infection with DENV-2 had no significant influence on virus replication which was assessed by estimating the viral RNA copy number using real time RT-PCR (Fig. 1A & C) or infectious virus particles by FFU assay (Fig. 1B & D).

Effect of 1,25(OH)2D3 on expression of genes coding for PRRs in DENV-2 infected cells

In U937-DC-SIGN cells, DENV-2 infection had no significant effect on the expression of TLR3 gene (P > 0.05) while

Discussion

Earlier reports have shown that 1,25(OH)2D3 suppresses DENV replication in U937 macrophages, Huh-7 cell line and human monocyte derived macrophages (MDM) [[9], [10], [11]]. In subjects orally given 4000 IU of 1,25(OH)2D3 twice daily, MDM enhanced DENV replication while in subjects given 7000 IU of 1,25(OH)2D3 twice daily, MDM restricted DENV replication [9]. In another study, MDM differentiated in the presence of 1,25(OH)2D3 and stimulated with interleukin (IL)-4 inhibited the replication of

Acknowledgements

The authors acknowledge the contributions of Mr. Manoj Kumar Tomar (Deceased on 21.10.2016) in standardizing the experiments during initial period of the study.

Funding

The study was supported by grants (YSS/2014/000284) from Science and Engineering Research Board, Department of Science and Technology, Government of India to Kalichamy Alagarasu. Nandadeep J Jadhav worked as a Junior Research Fellow in the Project.

References (28)

  • M.M. Alen et al.

    Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection

    Virology

    (2009)
  • C. Pagliari et al.

    Human kidney damage in fatal dengue hemorrhagic fever results of glomeruli injury mainly induced by IL17

    J. Clin. Virol.

    (2016)
  • A.R. Martineau et al.

    High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

    Lancet

    (2011 Jan)
  • Y. Yang et al.

    Dependency of vaccine efficacy on preexposure and age: a closer look at a tetravalent dengue vaccine

    Clin. Infect. Dis.

    (2018)
  • Cited by (25)

    • Vitamin D and antiviral immunity

      2023, Feldman and Pike's Vitamin D: Volume Two: Disease and Therapeutics
    • Vitamin D modulates the expression of Toll-like receptors and pro-inflammatory cytokines without affecting Chikungunya virus replication, in monocytes and macrophages

      2022, Acta Tropica
      Citation Excerpt :

      Levels of IL10 are correlated with plasma leakage in DENV infected subjects and higher levels have been shown to be consistently associated with severe disease (Srikiatkhachorn and Green, 2010; Green et al., 1999). Further, in U937-DC-SIGN and THP-1 was reported that VD3 inhibited IL10 response at lower concentration while at higher concentration, IL10 response is nearly restored (Jadhav et al., 2018). However, given the important role of regulatory T lymphocytes in regulation of inflammatory and antiviral response (Zelinskyy et al., 2009), the production of IL10 during CHIKV infection may also diminish the protective effects of vitamin D.

    • Immunomodulatory effect of vitamin D on immune response to dengue virus infection

      2021, Vitamins and Hormones
      Citation Excerpt :

      MDMs and MDDCs derived from healthy subjects who received 1000 IU/day for 10 days showed increased replication of DENV compared to the cells from healthy subjects obtained before vitamin D treatment (Giraldo et al., 2018; Martínez-Moreno et al., 2020). Our studies demonstrated that 1,25(OH)2D3 exerted opposing effects of IL-12p70 and IL-10 production at 0.1 and 1 M concentrations (Jadhav et al., 2018). Achieving a optimal level of 1,25(OH)2D3 in circulation is essential for induction of beneficial effects against DENV infection and insufficient or deficient levels might deteriorate the beneficial effects against DENV infection.

    • Prevalence of obesity and hypovitaminosis D in elderly with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

      2020, Clinical Nutrition ESPEN
      Citation Excerpt :

      The immunomodulatory functions of vitamin D have received considerable attention because, in addition to its classic role in bone homeostasis involving calcium and phosphorus, vitamin D is a potent immunoregulatory. Vitamin D is thought to modulate immune responses by selective suppression of effector functions, such as the production of inflammatory cytokines and leukocyte infiltration, minimizing inflammation [30,31]. Recent findings also indicate a complex interaction between viral infections and vitamin D, including the induction of antiviral status, functional immunoregulatory characteristics, induction of autophagy and apoptosis [32].

    • Differential immunomodulatory effect of vitamin D (1,25 (OH)<inf>2</inf> D<inf>3</inf>) on the innate immune response in different types of cells infected in vitro with infectious bursal disease virus

      2020, Poultry Science
      Citation Excerpt :

      Vitamin D (Vit D) can modulate immune responses by selective suppression of effector functions such as proinflammatory cytokine production and leukocyte infiltration into inflammatory sites (Helming et al., 2005; Bahar-Shany et al., 2010; Jadhav et al., 2018).

    View all citing articles on Scopus
    View full text